Retraction Note to: Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study (Mol Biol Rep, (2012), 39, (8679-8685), 10.1007/s11033-012-1723-8);Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: A case control study

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 8679-8685

  Zhu, Qing ^a   Liu, Tongtao ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Coronary artery disease; Fibroblast growth factor receptor 4; Polymorphisms

Indexed keywords

ARGININE; CHOLESTEROL; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CODON; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FGFR4 GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84865134106     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-016-3985-z     Document Type: Erratum

References (33)

1. Gaziano TA, Britton A, Anand S, Abrahams-Gessel S, Murphy A (2010) Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 35:72-115
2. Jackson CL, Reidy MA (1993) Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 143:1024-1031 (Pubitemid 24070543)
3. Winkles JA, Friesel R, Burgess WH, Howk R, Mehlman T, Weinstein R, Maciag T (1987) Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 84:7124-7128 (Pubitemid 18017321)
4. Tan EM, Levine E, Sorger T, Unger GA, Hacobian N, Planck B, Iozzo RV (1989) Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells. Biochem Biophys Res Commun 163:84-92 (Pubitemid 19227273)
5. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447 (Pubitemid 17009577)
6. Baird A, Mormede P, Bohlen P (1985) Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126:358-364 (Pubitemid 15173569)
7. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D (1987) Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257-259 (Pubitemid 17049885)
8. Hughes SE, Crossman D, Hall PA (1993) Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 27:1214-1219 (Pubitemid 23250899)
9. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68:106-113
10. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA (1991) Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA 88:8651-8655 (Pubitemid 21915415)
11. Reidy MA, Lindner V (1991) Basic FGF and growth of arterial cells. Ann N Y Acad Sci 638:290-299
12. Wu MT, Hwang ST (2002) CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigen-specific immune responses. J Immunol 168:5096-5102 (Pubitemid 34495973)
13. Casscells W, Lappi DA, Olwin BB, Wai C, Siegman M, Speir EH, Sasse J, Baird A (1992) Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci USA 89:7159-7163
14. Cuevas P, Gonzalez AM, Carceller F, Baird A (1991) Vascular response to basic fibroblast growth factor when infused on to the normal adventitia or into the injured media of the rat carotid artery. Circ Res 69:360-369
15. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ (1993) Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362:844-846 (Pubitemid 23132160)
16. Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D (1991) Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6:1195-1202 (Pubitemid 21924208)
17. Champion-Arnaud P, Ronsin C, Gilbert E, Gesnel MC, Houssaint E, Breathnach R (1991) Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 6:979-987 (Pubitemid 21924175)
18. Werner S, Duan DS, De Vries C, Peters KG, Johnson DE, Williams LT (1992) Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82-88
19. Templeton TJ, Hauschka SD (1992) FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFRI. Dev Biol 154:169-181
20. Mikawa T (1995) Retroviral targeting of FGF and FGFR in cardiomyocytes and coronary vascular cells during heart development. Ann N Y Acad Sci 752:506-516
21. Wang J, Yu W, Cai Y, Ren C, Ittmann MM (2008) Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 10:847-856
22. Frullanti E, Berking C, Harbeck N, Jézéquel P, Haugen A, Mawrin C, Parise O Jr, Sasaki H, Tsuchiya N, Dragani TA (2011) Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Eur J Cancer Prev 20:340-347
23. Wang W, Song H, Liu J, Song B, Cao X (2011) CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma. DNA Cell Biol. doi: 10.1089/dna.2011.1211
24. Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W (2011) Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol. doi: 10.1089/dna.2011.1269
25. Ma L, Song H, Zhang M, Zhang D (2011) Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol. doi: 10.1089/dna.2011.1261
26. Yang Y, Zhou Y, Lu M, An Y, Li R, Chen Y, Lu DR, Jin L, Zhou WP, Qian J, Wang HY (2011) Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Mol Carcinog. doi: 10.1002/mc.20805
27. Xu W, Li Y, Wang X, Chen B, Wang Y, Liu S, Xu J, Zhao W, Wu J (2010) Transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects. Eur J Cancer 46:3332-3338
28. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149 (Pubitemid 40616112)
29. Matsumoto-Yoshitomi S, Habashita J, Nomura C, Kuroshima K, Kurokawa T (1997) Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogene. Int J Cancer 71:442-450 (Pubitemid 27224311)
30. Leung HY, Gullick WJ, Lemoine NR (1994) Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 59:667-675 (Pubitemid 24358591)
31. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhönen S, Lehtovirta P, Nevanlinna H (1993) Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54:378-382 (Pubitemid 23169673)
32. Lehtola L, Partanen J, Sistonen L, Korhonen J, Wärri A, Härkönen P, Clarke R, Alitalo K (1992) Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer 50:598-603
33. Takahashi A, Sasaki H, Kim SJ, Kakizoe T, Miyao N, Sugimura T, Terada M, Tsukamoto T (1999) Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 257:855-859 (Pubitemid 29301531)